Curis, Inc. (CRIS)
USD 3.22
(-6.67%)
USD 3.22
(-6.67%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -38.43 Million | -54.33 Million | -37.61 Million | -25.73 Million | -26.2 Million | -30.06 Million |
| Net Income | -47.41 Million | -56.67 Million | -45.43 Million | -29.9 Million | -32.14 Million | -32.57 Million |
| Depreciation & Amortization | 255 Thousand | 233 Thousand | 158 Thousand | 144 Thousand | 125 Thousand | 177 Thousand |
| Deferred income taxes | -1.05 Million | - | 1.4 Million | 24 Thousand | 3.52 Million | 7000.00 |
| Stock-based compensation | 6 Million | 6.75 Million | 5.27 Million | 2.69 Million | 2.65 Million | 3.94 Million |
| Change in working capital | 2.77 Million | -6.81 Million | 1 Million | 1.04 Million | -1.55 Million | -1.5 Million |
| Other non-cash items | 1 Million | 2.16 Million | -26 Thousand | 255 Thousand | 1.18 Million | -112 Thousand |
| Investing Cash Flow | 37.78 Million | 33.02 Million | -47.89 Million | -49.04 Million | -4.45 Million | 21.37 Million |
| Investments in PPE | - | -416 Thousand | - | -677 Thousand | -41 Thousand | -85 Thousand |
| Acquisitions | - | - | - | - | - | 85 Thousand |
| Investment purchases | -70.34 Million | -62 Million | -93.12 Million | -53.44 Million | -11.46 Million | -26.74 Million |
| Sales/Maturities of investments | 108.12 Million | 95.43 Million | 45.23 Million | 5.07 Million | 7.05 Million | 48.2 Million |
| Other Investing Activities | - | - | - | - | - | -85 Thousand |
| Financing Cash Flow | 7.58 Million | 867 Thousand | -4.17 Million | 188.81 Million | 23.27 Million | -5.96 Million |
| Debt repayment | -6.53 Million | -4.97 Million | -4.47 Million | -3.39 Million | -38.98 Million | -6.1 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 14.11 Million | 5.59 Million | 300 Thousand | 193.22 Million | 68 Thousand | 143 Thousand |
| Other Financing Activities | -6.53 Million | 248 Thousand | -4.47 Million | -1.01 Million | 62.19 Million | -6.1 Million |
| Accounts receivables | 181 Thousand | 249 Thousand | -181 Thousand | 201 Thousand | -380 Thousand | 209 Thousand |
| Accounts payables | 3.34 Million | -3.88 Million | 4.96 Million | 1 Million | 60 Thousand | -1.87 Million |
| Inventory | - | - | - | - | - | 1.87 Million |
| Other working capital | -3.52 Million | -3.18 Million | -3.78 Million | -153 Thousand | -1.23 Million | -1.71 Million |
| Cash at beginning of period | 20.29 Million | 40.74 Million | 130.42 Million | 16.39 Million | 23.78 Million | 38.28 Million |
| Cash at end of period | 27.22 Million | 20.29 Million | 40.74 Million | 130.42 Million | 16.39 Million | 23.63 Million |
| Capital Expenditure | - | -416 Thousand | - | -677 Thousand | -41 Thousand | -85 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 6.93 Million | -20.44 Million | -89.68 Million | 114.02 Million | -7.39 Million | -14.65 Million |
| Free Cash Flow | -38.43 Million | -54.75 Million | -37.61 Million | -26.41 Million | -26.24 Million | -30.15 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -11.8 Million | -11.87 Million | -47.41 Million | -11.71 Million | -12.18 Million | -11.96 Million |
| Depreciation & Amortization | 62 Thousand | 418 Thousand | 255 Thousand | 64 Thousand | 63 Thousand | 64 Thousand |
| Deferred income taxes | - | - | -1.05 Million | 457 Thousand | -442 Thousand | -457 Thousand |
| Stock-based compensation | 1.7 Million | 1.55 Million | 6 Million | 1.54 Million | 1.63 Million | 1.42 Million |
| Change in working capital | -889 Thousand | -3.33 Million | 2.77 Million | -412 Thousand | 2.54 Million | 2.84 Million |
| Other non-cash items | 2.82 Million | 4.01 Million | 1 Million | -131 Thousand | 203 Thousand | 213 Thousand |
| Investing Cash Flow | -7.36 Million | 18.91 Million | 37.78 Million | 14.51 Million | 180 Thousand | -3.15 Million |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -7.36 Million | -10.73 Million | -70.34 Million | -5.68 Million | -36.32 Million | -10.65 Million |
| Sales/Maturities of investments | - | 29.65 Million | 108.12 Million | 20.2 Million | 36.5 Million | 7.5 Million |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | -1.46 Million | -2.4 Million | 7.58 Million | -2.11 Million | 12.55 Million | -852 Thousand |
| Debt repayment | -1.75 Million | -2.4 Million | -6.53 Million | -2.23 Million | -1.25 Million | -1.03 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 291 Thousand | - | 14.11 Million | 303 Thousand | 13.81 Million | 178 Thousand |
| Other Financing Activities | -1.75 Million | -2.4 Million | -6.53 Million | -185 Thousand | -1.25 Million | -1.03 Million |
| Accounts receivables | -392 Thousand | 640 Thousand | 181 Thousand | 54 Thousand | -462 Thousand | -72 Thousand |
| Accounts payables | -816 Thousand | -2.25 Million | 3.34 Million | 5.32 Million | 3.98 Million | 1.57 Million |
| Inventory | - | - | - | -1.32 Million | -3.98 Million | -1.57 Million |
| Other working capital | 319 Thousand | -1.72 Million | -3.52 Million | -4.47 Million | 3 Million | 2.92 Million |
| Cash at beginning of period | 29.95 Million | 26.68 Million | 20.29 Million | 25.01 Million | 20.45 Million | 32.33 Million |
| Cash at end of period | 9.99 Million | 29.95 Million | 27.22 Million | 27.22 Million | 25.01 Million | 20.45 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | -13.29 Million | -2.92 Million | 13.29 Million |
| Net cash flow / Change in cash | -19.96 Million | 3.27 Million | 6.93 Million | 2.21 Million | 4.55 Million | -11.87 Million |
| Free Cash Flow | -11.13 Million | -13.23 Million | -38.43 Million | -10.18 Million | -8.18 Million | -7.86 Million |
MNSB
WSPOF
CEAD
AANNF
NVZMF
0R18